论文部分内容阅读
The present study is directed to a novel pharmacological property of a- amyrin acetate derived from the latex of Tabernaemontana dichotoma as a potent a-glucosidase inhibitor, which has not been reported before.The present discovery also provides for the use of this compound as a new oral hypoglycemic drug in the treatment of type II diabetes being approximately 35 times potent compared with acarbose, a standard drug widely prescribed to type II diabetes patients.